Liminatus Pharma LIMN
NASDAQ LIMN
$3.02 -0.09 (-2.87%)
As of: Oct 23, 2026 · 11:19 AM EDT

Liminatus Pharma (LIMN) Net Debt Issuances and Repayments (2024 - 2025)

Updated

Analysis

Liminatus Pharma (LIMN) Net Debt Issuances and Repayments (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,133.17 Bn 1,101.76 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 634.79 Bn 554.65 Bn 17.30 Bn -4.36 Bn
3 AbbVie 506.40 Bn 479.51 Bn 12.70 Bn -2.00 Bn
4 Merck 357.93 Bn 312.31 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 292.69 Bn 256.68 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 265.19 Bn 238.87 Bn 12.86 Bn -2.46 Bn
7 Amgen 238.22 Bn 193.61 Bn 7.24 Bn -
8 Gilead Sciences 195.23 Bn 169.43 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn 64.00 Mn
10 Liminatus Pharma 2.92 Mn -3.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 3.63 Mn
Mar 31, 2025 713,000.00
Dec 31, 2024 700,000.00
Sep 30, 2024 983,000.00
API Access

Liminatus Pharma Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=LIMN&period=max&api_key=YOUR_API_KEY